Gerresheimer AG is to build a new plant in Skopje, Republic of North Macedonia. “As part of our growth strategy, we require additional manufacturing capacity and are expanding our European production network. We will build a new plant in Skopje to produce plastic systems for both the pharmaceutical industry and the medical technology sector as well as prefillable syringes. North Macedonia is an ideal location for expanding our production. The country offers good infrastructure, cost structures, trained personnel and excellent support from the authorities,” said Dietmar Siemssen, Chief Execu- tive Officer of Gerresheimer AG.
Gerresheimer is investing a mid-double-digit million Euro figure in the new plant in the North Macedonian capital of Skopje, an amount that is already included inthe company’s medium-term investment plans. Construction will begin in the first half of 2019, with completion scheduled for the first half of 2020. It is expected that start of production will take place in the second half of 2020. The plant will initially manufacture medical plastic systems prior to adding prefillable glass syringes lines following a further expansion phase. Up to 400 jobs may be created in the medium term. The plant will belong to the Plastics & Devices Division where it will fall under the Medical Systems Business Unit. Construction work, staff training and production ramp-up will be closely supervised and supported by the Gerresheimer competence center in Wackersdorf, Germany, together with European sister factories in Pfreimd and Buende in Germany as well as Horsovsky Tyn in the Czech Republic. Gerresheimer has production facilities in North and South America as well as in Europe and Asia. The Skopje plant will be Gerresheimer’s first in South-Eastern Europe.
About Gerresheimer
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers.
With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharma- ceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, micro pumps, prefillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.
07.03.2019, Gerresheimer AG
News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.